Additionally, the identification of HNF4α and HNF1α as mutated targets in cancer suggests that systematic searches through cancer cell genomes for somatic mutations will ultimately provide a full picture of the pathophysiology and therapeutic opportunities for underlying human oncogenesis. Here, HNF4A is linked to cancer.